Shilpa Medicare Limited (SHILPAMED) Share Analysis
NSE · Healthcare · Healthcare
Shilpa Medicare Limited (NSE: SHILPAMED) is an Indian listed company in the Healthcare sector and a constituent of NIFTY Microcap 250. As of 21 Sep 2026, the share price was ₹1,021.00, market capitalisation ₹19,971 Cr, P/E 70.2, ROE 8.99%.
Get the AI verdict on SHILPAMED: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
Stored fundamentals as of 21 Sep 2026 — not a live quote. Signed-in analysis uses same-day data.
SHILPAMED price and valuation
- Share price
- ₹1,021.00
- Market cap
- ₹19,971 Cr
- P/E ratio
- 70.2
- P/B ratio
- 7.73
- EPS
- ₹15.20
- Book value per share
- ₹132.00
- Dividend yield
- 0.06%
SHILPAMED profitability and growth
- ROE
- 8.99%
- ROCE
- 10.9%
- Debt to equity
- 0.25
- Revenue growth (3 yr)
- 14%
- Revenue growth (5 yr)
- 11%
- Profit growth (3 yr)
- 107%
- Profit growth (5 yr)
- 17%
SHILPAMED 52-week range
- 52-week high
- ₹1,033.10
- 52-week low
- ₹259.50
- Face value
- ₹1.00
SHILPAMED shareholding pattern
- Promoters
- 40.13%
- FIIs
- 11.39%
- DIIs
- 8.05%
- Public
- 40.42%
Index membership: NIFTY Microcap 250.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.